Search - tctmd.com

Displaying 261 - 280 of 841

Sort: Relevancy | Date

FDA Grants Tirzepatide a New Indication for Obesity Management

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

November 08, 2023

What’s Going to Be Hot at AHA 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

November 07, 2023

TCT 508: A Meta-Analysis on the Obesity Paradox in Patients Undergoing Transcatheter Aortic Valve Replacement

Presentation TCT 2023

TCT 508: A Meta-Analysis on the Obesity Paradox in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Nathan Matzko

October 26, 2023

TCT 438: Predictive Value of Abdominal Fat Distribution and Physique Stratified by Body Mass Index on Coronary Artery Disease Severity Using Computed Tomography-derived SYNTAX Score

Presentation TCT 2023

TCT 438: Predictive Value of Abdominal Fat Distribution and Physique Stratified by Body Mass Index on Coronary Artery Disease Severity Using Computed Tomography-derived SYNTAX Score

Presenter: Takuya Miyagi

October 26, 2023

TCT 307: Percutaneous Coronary Intervention Outcomes Stratified by Body Mass Index. Are Obesity Classes Created Equally? A Retrospective Population-Based Study

Presentation TCT 2023

TCT 307: Percutaneous Coronary Intervention Outcomes Stratified by Body Mass Index. Are Obesity Classes Created Equally? A Retrospective Population-Based Study

Presenter: Carlos Gaibor

October 26, 2023

TCT 298: Bariatric Arterial Embolization: a Mini-invasive Procedure for Treating Obesity

Presentation TCT 2023

TCT 298: Bariatric Arterial Embolization: a Mini-invasive Procedure for Treating Obesity

Presenter: Gustavo Samaja

October 26, 2023

TCT 13: Metabolic Syndrome, a new predictor of coronary artery calcification burden: An Optical Coherence Tomography Study

Presentation TCT 2023

TCT 13: Metabolic Syndrome, a new predictor of coronary artery calcification burden: An Optical Coherence Tomography Study

Presenter: Francesca Maria Di Muro

October 26, 2023

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Presentation TCT 2023

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Presenter: Minju Han

October 25, 2023

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

News Daily News

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

Yael L. Maxwell

October 12, 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 11, 2023

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

News Daily News

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

October 10, 2023

Positive Phase III Results Bring Excitement for Novel PET Imaging Tracer

News Daily News

Positive Phase III Results Bring Excitement for Novel PET Imaging Tracer

October 10, 2023

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

October 06, 2023

To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke

News Daily News

To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke

October 03, 2023

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

News Daily News

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

September 28, 2023

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

News Daily News

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

September 25, 2023

Slight Declines in Kidney Function Portend CV Trouble for Young Adults

News Daily News

Slight Declines in Kidney Function Portend CV Trouble for Young Adults

September 18, 2023

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.